Top

Published in:

01-10-2008 | Editorial

Surgery for Diabetes at Lower BMI: Some Caution

Author: Mervyn Deitel

Published in: Obesity Surgery | Issue 10/2008

Excerpt

Many thousands of years ago, our ancestors were hunter–gatherers and performed arduous labor. They hunted animals and also ate some fibrous roots, berries, and nuts—a diet high in protein with some complex carbohydrates [1‐3]. This coincides with a diet with a low glycemic index [4, 5]. These meals were irregular and sometimes infrequent, and when there was a “kill”, the entire clan would share the meal. Through natural selection, early man developed “thrifty” genes for times of famine [6]. …

Deitel M. The obesity epidemic (editorial). Obes Surg. 2006;16:377–8.PubMedCrossRef

Eades MR, Eades MD. Protein Power. New York: Bantam, 1996 (ISBN 0553574752).

Brody H. The other side of Eden: hunter–gatherers, farmers and the shaping of the world. UK: Faber & Faber, 2002 (ISBN 10:057120502X).

Jenkins DJ, Wolever TM, Taylor RH, et al. Glycemic index of foods: a physiological basis for carbohydrate exchange. Am J Clin Nutr. 1981;34:362–6.PubMed

Jenkins DJ, Kendall CW, Augustin LS, et al. Glycemic index: overview of implications in health and disease. Am J Clin Nutr 2002;76:266S–73S.PubMed

Baier LJ, Hanson RL. Genetic studies of the etiology of type 2 diabetes in Pima Indians. Diabetes. 2004;53:1181–6.PubMedCrossRef

Reaven GM. The individual components of the metabolic syndrome: is there a raison d’etre? J Am Coll Nutr 2007;26:191–5.PubMed

Sanderson I, Deitel M. Insulin response in patients receiving concentrated infusions of glucose and casein hydrolysate for complete parenteral nutrition. Ann Surg. 1974;179:387–94.PubMedCrossRef

Gumbs AA, Modlin AM, Ballantyne GH. Changes in insulin resistance following bariatric surgery: role of caloric restriction and weight loss. Obes Surg. 2005;15:462–73.PubMedCrossRef

10.

Wickremesekera K, Millor G, Naotunne TD, et al. Loss of insulin resistance after Roux-en-Y gastric bypass surgery: a time course study. Obes Surg. 2005;15:474–81.PubMedCrossRef

11.

Sanderson I, Deitel M, Bojm MA. The handling of glucose and insulin response before and after weight loss with jejuno-ileal bypass: a preliminary report. JPEN 1983;7:274–6.

12.

Deitel M, Sidhu PS, Stone E. Effect of vertical banded gastroplasty on diabetes in the morbidly obese. Obes Surg 1991;1:113–4. (abstr).

13.

Keith SH, Mason EE, Scott DH, et al. Serum insulin and glucose levels, and insulin binding kinectics, in morbid and super obese patients undergoing vertical banded gastroplasty. Obes Surg. 1991;1:112. (abstr).

14.

Smith SG, Edwards CB, Goodman GM. Changes in diabetic management after Roux-en-Y gastric bypass. Obes Surg. 1996;6:345–8.PubMedCrossRef

15.

Halverson JD, Kramer J, Cave A, et al. Altered glucose tolerance, insulin response, and insulin sensitivity after massive weight reduction subsequent to gastric bypass. Surgery. 1982;92:235–40.PubMed

16.

Deitel M. The early effect of bariatric operations on diabetes (commentary). Obes Surg. 2002;12:349.PubMedCrossRef

17.

Dixon JB, Dixon AF, O’Brien PE. Improvement in insulin sensitivity and beta cell function (HOMA) with weight loss in the severely obese. Homeostatic model assessment. Diab Med. 2003;20:127–34.CrossRef

18.

Burstein R, Epstein Y, Charuzi I, et al. Glucose utilization in morbidly obese subjects before and after weight loss by gastric bypass operation. Int J Obes. 1995;19:558–61.

19.

Pories WJ. Why does the gastric bypass control type 2 diabetes mellitus? Obes Surg. 1992;2:303–13.PubMedCrossRef

20.

Rubino F, Forgione A, Cummings DE, et al. The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes. Ann Surg. 2006;244:741–9.PubMedCrossRef

21.

Lamounier RN, Pareja JC, Tambascia MA, et al. Incretins: clinical physiology and bariatric surgery—correlating the entero-endocrine system and a potentially anti-dysmetabolic procedure. Obes Surg. 2007;17:569–76.PubMedCrossRef

22.

Näslund E, Backman L, Holst JJ, et al. Importance of small bowel peptides for the improved glucose metabolism 20 years after jejunoileal bypass for obesity. Obes Surg. 1998;8:253–60.PubMedCrossRef

23.

Mason EE. Gastric emptying controls type 2 diabetes mellitus (editorial). Obes Surg. 2007;17:853–5.PubMedCrossRef

24.

Valverde I, Puente J, Martin-Duce A, et al. Changes in glucagons-like peptide-1 (GLP-1) secretion after biliopancreatic diversion or vertical banded gastroplasty in obese subjects. Obes Surg. 2005;15:387–97.PubMedCrossRef

25.

Livingston EH. Lowering the bariatric surgery minimum body mass index threshold. Arch Surg. 2008;143:708–10.PubMedCrossRef

26.

Cohen RV, Schiavon GA, Pinheiro JC, et al. Duodenal–jejunal bypass for the treatment of type 2 diabetes in patients with BMI 22-34: a report of 2 cases. Surg Obes Relat Dis. 2007;3:195–7.PubMedCrossRef

27.

Scopinaro N, Papadia F, Marinari G, et al. Long-term control of type 2 diabetes mellitus and the other major components of the metabolic syndrome after biliopancreatic diversion in patients with BMI <35 kg/m². Obes Surg. 2007;17:185–92.PubMedCrossRef

28.

Melissas J, Daskalakis M, Koukouraki S, et al. Sleeve gastrectomy—a “food limiting” operation. Obes Surg. 2008;18:Oct (in press).

29.

Frühbeck G, Diez-Caballero A, Gil MJ, et al. The decrease in plasma ghrelin concentrations following bariatric surgery depends on the functional integrity of the fundus. Obes Surg. 2004;14:606–12.PubMedCrossRef

30.

Mason EE. Ileal transposition and enteroglucagon/GLP-1 in obesity (and diabetic?) surgery. Obes Surg. 1999;9:223–8.PubMedCrossRef

31.

DePaula AL, Macedo ALV, Rossi N, et al. Laparoscopic treatment of type 2 diabetes mellitus for patients with body mass index less than 35. Surg Endosc. 2008;22:706–16.PubMedCrossRef

32.

Zimmet P, Turner R, McCarty D, et al. Crucial points at diagnosis. Type 2 diabetes or slow type 1 diabetes. Diab Care. 1999;22:B59–64.

33.

Landin-Olsson M. Latent autoimmune diabetes in adults. Ann NY Acad Sci. 2002;958:112–6.PubMedCrossRef

34.

Seisser J. Latent (slowly progressing) autoimmune diabetes in adults. Curr Diab Rep. 2008;8:94–100.CrossRef

35.

Brophy S, Yderstraede K, Mauricio D, et al. Time to insulin initiation cannot be used in defining latent autoimmune diabetes in adults. Diab Care. 2008;31:439–41.CrossRef

36.

Drucker DJ, Nauck MA. The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitor in type 2 diabetes. Lancet. 2006;368(9548):1696–705.PubMedCrossRef

37.

Madsbad S, Krarup T, Deacon CF, et al. Glucagon-like peptide receptor agonists and dipeptyl peptidase-4 inhibitors in the treatment of diabetes: a review of clinical trials. Curr Opin Clin Nutr Metab Care. 2008;11:491–9.PubMedCrossRef

Title: Surgery for Diabetes at Lower BMI: Some Caution
Author: Mervyn Deitel
Publication date: 01-10-2008
Publisher: Springer-Verlag
Published in: Obesity Surgery / Issue 10/2008
Print ISSN: 0960-8923
Electronic ISSN: 1708-0428
DOI: https://doi.org/10.1007/s11695-008-9674-9

At a glance: The STEP trials

Springer Medicine

Surgery for Diabetes at Lower BMI: Some Caution

Excerpt

At a glance: The STEP trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 10/2008

Limitations of the Millon Behavioral Medicine Diagnostic (MBMD) with Bariatric Surgical Candidates

Bowel Habits After Bariatric Surgery

Distal Esophageal Erosion After Laparoscopic Adjustable Gastric Band Placement with Nissen Fundoplication Takedown

Gastroesophageal Reflux Disease in Morbid Obesity: The Effect of Roux-en-Y Gastric Bypass

Laparoscopic Sleeve Gastrectomy without an Over-Sewing of the Staple Line

Histological Alterations Following Bariatric Surgery: Pilot Study